![]() With this approval, the COMIRNATY vials can be stored in all 27 European Union (EU) member states at these updated temperatures for a total of two weeks alternatively to the storage at ultra-low temperatures. ![]() The new data is a testament to the companies’ ongoing commitment to developing this vaccine further and collecting data in order to support broader and more flexible vaccine distribution and inoculation. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Medicines Agency (EMA) approved storage of COMIRNATY® at -25☌ to -15☌ for a total of two weeks based on data showing the stability at these temperatures in standard pharmaceutical freezers. New York and Mainz, Germany, MaPfizer Inc. Label update offers greater flexibility for distributing, storing and administering the vaccine within the European Union.New stability data show vaccine can be stored at -25☌ to -15☌ for a total of two weeks and support decentralized distribution plans for vaccination at general practitioners’ offices.Research and Business Development Partnerships.Unleashing the next wave of scientific innovations
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |